[{"orgOrder":0,"company":"HempMeds","sponsor":"Not Applicable","pharmaFlowCategory":"DU","amount":"Not Applicable","upfrontCash":"Not Applicable","newsHeadline":"Medical Marijuana, Inc. Subsidiary HempMeds\u00ae Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point","therapeuticArea":"Neurology","highestDevelopmentStatus":"Approved","country":"BRAZIL","productType":"Small molecule","productStatus":"Approved","date":"January 2023","url1":"","url2":"","graph1":"Neurology","graph2":"Approved"},{"orgOrder":0,"company":"HempMeds","sponsor":"Not Applicable","pharmaFlowCategory":"DU","amount":"Not Applicable","upfrontCash":"Not Applicable","newsHeadline":"Medical Marijuana, Inc. Participates in Preclinical Research Study on Therapeutic Benefits of CBD on Traumatic Brain Injuries","therapeuticArea":"Trauma (Emergency, Injury, Surgery)","highestDevelopmentStatus":"Preclinical","country":"BRAZIL","productType":"Small molecule","productStatus":"Approved","date":"February 2023","url1":"","url2":"","graph1":"Trauma (Emergency, Injury, Surgery)","graph2":"Preclinical"}]
Find Clinical Drug Pipeline Developments & Deals by HempMeds
Cannabidiol, a plant-derived cannabis-based medicine which is act CB receptor agonist, is administered orally for the treatment of traumatic brain injuries in preclinical studies.
RSHO-X is company's line of Isolated CBD products that include, oils and powders. Cannabidiol is a plant-derived cannabis-based medicine which acts as CB receptor agonist, and is used for CDKL5 epilepsy.